ArticleHeart rhythm O22025
Temporal trends of atrioventricular block in acute coronary syndrome patients from the ACSIS registry.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-degree atrioventricular block (HDAVB) is a life-threatening complication among acute coronary syndrome (ACS). Objective: Our aim was to investigate temporal trends of the last two decades in incidence and prognosis of patients with HDAVB among patients who present with ACS. Methods: We evaluated 18,717 ACS patients from the multicenter ACSIS (Acute Coronary Syndrome Israeli Survey) registry. Temporal trends were examined in early (2000-2010) and late (2013-2021) periods. Results: Overall, HDAVB was diagnosed in 657 (3.5%) patients: 489 (4.25%) patients in the early period vs 168 (2.33%) in the late period ( Conclusion: ACS patients with HDAVB experience elevated short- and long-term mortality rates overall. However, there is improvement in outcomes for this population throughout the years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.